Oral Anticancer Therapies

Ayesha Saeed, Liaqat Hussain, Hua Naranmandura, Qian Qian Wang, Muhammad Yasir Ali, Ummaima Shahzad, Ijaz Ali

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Cancer is a common and diverse disease that has been studied for decades. Some tumors have rapid growth while some tumors progress slowly. Researchers have identified different types of anticancer drugs that control cell division and multiplication. But there is an urge to identify new anticancer agents, as tumor cells somehow, succeed in developing resistance. Some anticancer drugs target uncontrolled dividing cells and cause cell cycle arrest while some drugs are used as targeted agents that earmark the mutated receptors and block tumor formation. This chapter describes the primary targets of anticancer drugs, including enzymes involved in cellular replication and particular mutations in receptors leading to tumor development. Targeted drug therapy works more efficiently and produces remission. All anticancer drugs possess teratogenic effects.

Original languageEnglish
Title of host publicationCancer Targeting Therapies
Subtitle of host publicationConventional and Advanced Perspectives
PublisherCRC Press
Pages97-114
Number of pages18
ISBN (Electronic)9781000982930
ISBN (Print)9781032426259
DOIs
StatePublished - 1 Jan 2023
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2024 selection and editorial matter, Muhammad Yasir Ali, Shazia Anwer Bukhari; individual chapters, the contributors.

ASJC Scopus subject areas

  • General Medicine
  • General Pharmacology, Toxicology and Pharmaceutics

Fingerprint

Dive into the research topics of 'Oral Anticancer Therapies'. Together they form a unique fingerprint.

Cite this